Results
The results of our study show that the application of Suprefort led to the positive changes of glucose
tolerance test indices in patients of the 2nd group (214 people). In 195 patients (91.1 %) indices of the
blood glucose level reached the upper limit of the norm on the 18th day of treatment. In 114 cases
(53.3 %), the dose of the conventional drugs was reduced. It is also necessary to mention the stabilization
of positive developments over the next 3-4 months after treatment in 168 patients (78.5 %). We also
managed to improve the indicators of the sugar curve in the application of complex treatment using En
doluten, Suprefort, and Cerluten in all 3 groups of patients (375 people). Normalization of blood glucose
was achieved on day 12 of the treatment in 348 patients (92.8 %). In 279 patients (74.4 %) the dose of
conventional drugs was reduced. Positive changes were stabilized within 4-5 months after a treatment
course in 297 patients (79.2 %). Applying the course of common drugs in the first group (329 people)
to achieve improved indicators of the sugar curve failed on day 22 of the treatment in 286 patients
(86.9 %). In neither case, the dose of hypoglycemic drugs wasn’t reduced, and in 182 cases (55.3 %), it
has been increased to normalize blood glucose levels.
The research data is presented in Diagram 1 and Table 3.
Comparison of the effectiveness of traditional treatment schemes and schemes with ad Diagram 1
dition of peptide preparations in patients with diabetes (data displayed in percentage)
100 Traditional scheme
50
Suprefort + traditional treatment
0 scheme
50
Suprefort, Endoluten, Cerluten +
-100 traditional treatment scheme
Improvement of Glucose level Decrease of a drug Effect stabilization
fasting normalization dosage
Influence of traditional scheme and complex scheme with addition of peptides on Table 3
glucose level in blood in case of diabetes
Blood 1 group 2 group 3 group
glucose level
(mmol / I) Before Standard Before Standard+ Before Standard treatment
treatment scheme treatment Suprefort + peptide complex:-
Suprefort, Endoluten,
Cerluten
Fasting 8.4±0.6 6.8±0.6 * 8.2±0.7 6.1±0.5 ** 8.3±0.7 5.6±0.4 **
Two-hour 13.8±0.4 9.7±0.5 * 13.4±0.6 7.3±0.6 ** 13.6±0.6 6.5±0.4 **
post-load
glucose
* Reliable in comparison with data before treatment.
** Reliable in comparison with 1st group data.
Seoul, South Korea 2013
Для таблиц, дозировок и примечаний сверяйтесь с оригинальным PDF: при извлечении текста порядок колонок может измениться.
Из библиотеки Peptides. Авторство и содержание оригинала сохранены. Размещено с разрешения поставщика.